Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging
- PMID: 14618554
- DOI: 10.1002/gps.1010
Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging
Abstract
Objective: To confirm that performance in verbal learning and memory test (Rey's Auditory Verbal Learning Test-RAVLT) is a helpful early neuropsychological marker of dementia of Alzheimer's type (DAT).
Methods: RAVLT was administered as part of a more extensive neuropsychological battery at baseline evaluation in 116 unselected patients referred by subjective memory complaints (SMC). Patients were followed longitudinally for 2 years (average interval of 27.7+/-4 months). Seventy patients were included in the study: 27 developed probable DAT; 17 were diagnosed as cognitively normal persons and 26 were diagnosed with Mild Cognitive Impairment (MCI). Remaining patients abandoned or they did not meet the criteria for DAT, MCI or control. Performance on RAVLT at the baseline evaluation was compared between groups.
Results: Patients diagnosed two years later with probable DAT showed lower results, more frequently performed a score of zero at the delayed recall test (Trial 6) and had a percentage of forgetting (difference between Trials 5 and 6) higher than 75%. Score at delayed recall test and percentage of forgetting correlated with functional scales such as MMSE, Geriatric Depression Screening, Informant Questionnaire and Blessed's Dementia Rating.
Conclusions: RAVLT could help to identify those patients with SMC who would progress to DAT over a few years, and also to differentiate between the preclinical phase of Alzheimer's disease, mild cognitive impairment and normal aging. A score of zero at the delayed recall test or a percentage of forgetting > or =75% in patients with SMC is suggestive of probable DAT in the future.
Copyright 2003 John Wiley & Sons, Ltd.
Similar articles
-
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].Encephale. 2003 May-Jun;29(3 Pt 1):266-72. Encephale. 2003. PMID: 12876552 French.
-
Semantic knowledge of famous people in mild cognitive impairment and progression to Alzheimer's disease.Dement Geriatr Cogn Disord. 2004;17(3):188-95. doi: 10.1159/000076355. Epub 2004 Jan 20. Dement Geriatr Cogn Disord. 2004. PMID: 14739543 Clinical Trial.
-
Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.Dement Geriatr Cogn Disord. 2007;23(3):184-93. doi: 10.1159/000098562. Epub 2007 Jan 12. Dement Geriatr Cogn Disord. 2007. PMID: 17220629
-
Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.Clin Ther. 2006 Jul;28(7):991-1001. doi: 10.1016/j.clinthera.2006.07.006. Clin Ther. 2006. PMID: 16990077 Review.
-
[Mild Cognitive Impairment or pre-demential Alzheimer's disease?].Rev Neurol (Paris). 2002;158(10 Suppl):S30-4. Rev Neurol (Paris). 2002. PMID: 12529583 Review. French.
Cited by
-
Level of recall, retrieval speed, and variability on the Cued-Recall Retrieval Speed Task (CRRST) in individuals with amnestic mild cognitive impairment.J Int Neuropsychol Soc. 2012 Mar;18(2):260-8. doi: 10.1017/S1355617711001664. Epub 2012 Jan 23. J Int Neuropsychol Soc. 2012. PMID: 22265423 Free PMC article.
-
A computerized, self-administered test of verbal episodic memory in elderly patients with mild cognitive impairment and healthy participants: A randomized, crossover, validation study.Alzheimers Dement (Amst). 2018 Sep 27;10:647-656. doi: 10.1016/j.dadm.2018.08.010. eCollection 2018. Alzheimers Dement (Amst). 2018. PMID: 30456291 Free PMC article.
-
The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's disease.Hum Brain Mapp. 2023 Jun 1;44(8):3147-3157. doi: 10.1002/hbm.26269. Epub 2023 Mar 20. Hum Brain Mapp. 2023. PMID: 36939138 Free PMC article.
-
APOE ε4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer's Disease.Neuropsychiatr Dis Treat. 2020 Apr 8;16:923-931. doi: 10.2147/NDT.S235395. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32308396 Free PMC article.
-
Genome-Wide association study of quantitative biomarkers identifies a novel locus for alzheimer's disease at 12p12.1.BMC Genomics. 2022 Jan 28;23(1):85. doi: 10.1186/s12864-021-08269-8. BMC Genomics. 2022. PMID: 35086473 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
